FilingReader Intelligence
Cao Fei launches tender offer for Hubei Jumpcan shares
July 4, 2025 at 09:19 AM UTC•By FilingReader AI
Hubei Jumpcan Pharmaceutical (SSE:600566) faces a tender offer from Cao Fei, prompted by a recent internal equity transfer within Jumpcan Holding. Cao Fei acquired a 10.10% stake in Jumpcan Holding from Cao Longxiang for CNY 10.10 million. This transfer triggered a mandatory tender offer, as Cao Fei's indirect holding in Hubei Jumpcan now exceeds 30%, reaching 56.07% through Jumpcan Holding and Xizang Jumpcan.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Report of the Board of Directors of Hubei Jichuan Pharmaceutical Co., Ltd. to all shareholders on Cao Fei's tender offerJuly 4, 2025 at 08:00 AM UTC
Hubei Jichuan Pharmaceutical Co., Ltd.'s Second Indicative Announcement on Mr. Cao Fei's Tender Offer for the Company's SharesJuly 4, 2025 at 08:00 AM UTC
SSE:600566•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Hubei Jumpcan Pharmaceutical publishes news
Free account required • Unsubscribe anytime